Leaflet LAMPRENE 50mg soft capsules

Indicated for: leprosy

Route of administration: oral

Substance: clofazimin (anti-tuberculosis agent)

ATC: J04BA01 (Antiinfectives for systemic use | Drugs for treatment of lepra)

Precautions:
Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Requires periodic laboratory tests
Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Clofazimine is a medication used to treat leprosy and other bacterial infections caused by Mycobacterium. It works by inhibiting bacterial growth and reducing inflammation associated with the infection.

The medication is taken orally, usually in capsule form, and should be used as directed by your doctor. Treatment is long-term, and adherence to the prescribed regimen is essential for successful therapy.

Side effects may include discoloration of the skin, eyes, and urine, dry skin, or gastrointestinal disturbances. In rare cases, severe allergic reactions or other complications may occur, requiring immediate medical attention.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as liver diseases, to ensure the safe use of clofazimine.

General data about LAMPRENE 50mg

  • Substance: clofazimin
  • Date of latest medicines list: 16-08-2017
  • Product code: W63633001
  • Concentration: 50mg
  • Pharmaceutical form: soft capsules
  • Quantity: 100
  • Product type: Generic medicine
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Pharmaceutical forms available for clofazimin

Concentrations available for clofazimin

  • 100mg
  • 50mg

Combinations with other substances